Werewolf Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ACRV
Acrivon Therapeutics, Inc. Common Stock |
$1.33 | $41.70 M | -0.62 | 75 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$14.33 | $1.51 B | -9.26 | 117 |
![]() CGEM
Cullinan Oncology, Inc. |
$7.92 | $467.39 M | -2.86 | 111 |
![]() CELC
Celcuity Inc. |
$11.85 | $448.34 M | -3.88 | 87 |
![]() IKNA
Ikena Oncology, Inc. |
$1.34 | $64.42 M | -1.53 | 10 |
![]() CCCC
C4 Therapeutics, Inc. |
$1.54 | $109.71 M | -1.04 | 110 |
![]() MNOV
MediciNova, Inc. |
$1.34 | $65.23 M | -5.78 | 13 |
![]() ACET
Adicet Bio, Inc. |
$0.66 | $54.44 M | -0.51 | 152 |
![]() PASG
Passage Bio, Inc. |
$0.33 | $20.08 M | -0.32 | 60 |
![]() STOK
Stoke Therapeutics, Inc. |
$11.81 | $643.97 M | 14.38 | 128 |
![]() VOR
Vor Biopharma Inc. |
$0.55 | $67.90 M | -0.36 | 159 |
![]() THRD
Third Harmonic Bio, Inc. |
$5.42 | $244.59 M | -4.37 | 31 |
![]() DSGN
Design Therapeutics, Inc. |
$3.95 | $225.37 M | -4.01 | 56 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$4.77 | $292.79 M | 39.67 | 142 |
![]() CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.47 | $57.52 M | -5.6 | 2 |
![]() ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
![]() CSBR
Champions Oncology, Inc. |
$7.43 | $104.67 M | 16.82 | 210 |
![]() MOLN
Molecular Partners AG |
$3.82 | $136.10 M | -1.77 | 158 |
![]() TALS
Talaris Therapeutics, Inc. |
$2.72 | $116.44 M | -1.56 | 84 |
![]() DBTX
Decibel Therapeutics, Inc. |
$4.91 | $123.37 M | -1.93 | 68 |